CONNECT MIOT
MIOT International Becomes the First Hospital in India to Receive IASIOS Accreditation
Setting New Benchmarks in Interventional Oncology
MIOT International is proud to announce a historic milestone: we are the 1st hospital in India to receive IASIOS Accreditation, a global recognition awarded exclusively for excellence in Interventional Oncology (IO).
This prestigious accreditation is held by only 35 centres worldwide, and MIOT is honoured to stand among them. It reinforces our commitment to delivering world-class, patient-centred cancer care, right here in India.
What is IASIOS Accreditation?
IASIOS stands for the International Accreditation System for Interventional Oncology Services. It is the world’s only accreditation dedicated to assessing the quality and safety of cancer treatments delivered by interventional radiologists.
Developed by the European Society of Interventional Radiology, IASIOS evaluates hospitals on how well they deliver Interventional Oncology services throughout the entire patient pathway, from diagnosis and treatment to follow-up care.
Why Does IASIOS Accreditation Matter?
Being IASIOS Accredited means that MIOT:
- Meets international standards for quality and safety in Interventional Oncology treatments
- Offers structured, evidence-based clinical pathways
- Is fully equipped with the right technology, expertise, and training
- Is committed to continuous quality improvement and patient safety
- Fosters interdisciplinary teamwork among oncologists, radiologists, surgeons, and other specialists in cancer care.
This accreditation is a powerful reassurance for patients and families: you are receiving care that’s globally benchmarked for quality.
What Makes IASIOS Important in Cancer Care?
Interventional Oncology (IO) is a cutting-edge speciality offering minimally invasive, image-guided cancer treatments with fewer side effects and faster recovery. These procedures target cancer in organs like the liver, lungs, kidneys, bones, lymph nodes, and more, without open surgery.
By receiving IASIOS accreditation, it is proven that MIOT’s Interventional Oncology services are:
- Comprehensive across multiple cancer types and organs
- Safe and effective, using the latest technologies
- Delivered with precision and patient-centred care
MIOT’s Tumour Board
At the heart of MIOT’s excellence in cancer care is our robust, 35-member Tumour Board, a multidisciplinary panel of:
- Interventional radiologists
- Medical and surgical oncologists
- Radiation oncologists
- Pathologists
- Organ-specific specialists (gastroenterology, pulmonology, nephrology & hepatology)
- Palliative care experts and oncology nurses
The Tumour Board meets regularly to review each case and jointly design personalised treatment plans. This collaborative approach ensures that every patient benefits from the combined wisdom and expertise of specialists across departments, leading to better decision-making and superior outcomes.
The Tumour Board was a key factor in MIOT’s successful IASIOS accreditation, it reflects our commitment to team-based, patient-first cancer care.
How Was MIOT Certified?
IASIOS Accreditation was certified by evaluating the
- Expertise of MIOT’s IO doctors, nurses, and technicians
- Volume and variety of IO procedures performed at MIOT
- Facility infrastructure and treatment planning
- Safety and radiation protection protocols
- Clinical documentation, case reviews, and patient outcomes
- Participation in clinical research and innovation
Precision Cancer Treatment Through Interventional Procedures
Interventional Oncology (IO) is a rapidly advancing branch of cancer care that uses minimally invasive, image-guided procedures to diagnose and treat tumours with high precision. These treatments are often performed through tiny incisions or catheters, targeting cancer directly at the source while sparing healthy tissue. These procedures offer patients significant advantages, including fewer side effects, shorter recovery times, and the option to avoid major surgery. Many cases that were previously considered inoperable can now be treated effectively with IO procedures.
Why MIOT Stands Out
MIOT has always led the way in adopting the latest, proven treatments. Being the first hospital in India to receive IASIOS accreditation is a recognition of:
- Our pioneering work in Interventional Oncology
- Our high volume of successful procedures
- Our International standards in safety and patient care
- Our commitment to research, education, and excellence
- Qualified specialists in advanced IO procedures
Advanced IO Treatments at MIOT
MIOT’s Interventional Radiology Department provides advanced, minimally invasive treatments for cancers in various organ systems:
- Liver: TACE, TARE, thermal ablation
- Kidney, Lung, Lymph Nodes: Thermal ablation
- Bone & Soft Tissue Tumours: Cryoablation
- Thyroid: Thermal ablation of nodules
- Pain Management: Nerve blocks, neurolysis for cancer pain relief
Each procedure follows standardised protocols to ensure accuracy, safety, and optimal patient outcomes.
How Patients Benefit from MIOT Being IASIOS Accredited?
- Higher Standards, Better Outcomes You receive care aligned with global quality benchmarks.
- Safe, Patient-Centred Treatment Our focus is always on your comfort, dignity, and results.
- Clear Communication & Patient Guides We help you understand your options and make informed decisions.
- Trust & Confidence Choose MIOT with the assurance of international-quality cancer care.
- Greater Access to Advanced IO As part of the IASIOS global network, we bring world-class IO care closer to you.
Why Do International Patients Choose MIOT for Cancer Care?
As the only IASIOS-accredited hospital in India, MIOT offers global patients:
- Internationally recognised, safe, and effective interventional oncology treatments
- Expert medical teams, multilingual support, and personalised care
- End-to-end support from travel assistance to medical documentation
- A trusted destination for affordable, world-class cancer care
Choose MIOT International – Where Innovation Meets Accreditation
IASIOS Accreditation is not just a badge; it is a reflection of MIOT’s commitment to cancer patients and relentless pursuit of quality. We are proud to set a new benchmark in India for minimally invasive, advanced cancer care.